v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development, net of grants $ 4,456 $ 4,759 $ 8,957 $ 8,976
General and administrative, net of grants 2,418 2,703 4,864 5,044
Total operating expenses 6,874 7,462 13,821 14,020
Loss from operations (6,874) (7,462) (13,821) (14,020)
Other income, net 504 318 671 574
Net loss $ (6,370) $ (7,144) $ (13,150) $ (13,446)
Net loss per common share - basic (in dollars per share) $ (0.07) $ (0.12) $ (0.16) $ (0.23)
Net loss per common share - diluted (in dollars per share) $ (0.07) $ (0.12) $ (0.16) $ (0.23)
Weighted average shares outstanding - basic (in shares) 87,090 59,244 84,196 59,240
Weighted average shares outstanding - diluted (in shares) 87,090 59,244 84,196 59,240